Metoject® PEN

Metoject® PEN is a licensed, single use, 50mg/ml pre-filled methotrexate auto injector which is used to treat the following conditions:

  • Active Rheumatoid Arthritis (RA)
  • Severe, active Juvenile Idiopathic Arthritis (JIA)
  • Moderate to severe Psoriasis
  • Severe Psoriatic Arthritis
  • Mild to moderate Crohn’s disease

The active substance in Metoject® PEN is methotrexate.  Metoject® PEN is available in the following doses.

Metoject® PEN characteristics

  • One button activation
  • Room temperature storage
  • 24 months shelf life from date of manufacture
  • Automatic needle shield protection
  • Preservative and latex free
  • Colour coded for clear dosage identification
  • Single use

Dosage colour coding:

Doses

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. Please also report side effects to medac at: drugsafety@medac.de
By reporting side effects, you can help provide more information on the safety.